Brief: Somalogic Q3 basic EPS USD -0.12
08/11/2023 23:00
Nov 8 (Reuters) - Somalogic Q3 revenue USD 17.866 million. * Q3 basic EPS USD -0.12 * Q3 net income USD -22.157 million * Q3 gross margin 47.2% * Q3 adjusted EBITDA USD -20.1 million
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders